Home › Trial NCT02292758
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
- Trial IDNCT02292758
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorAcademic and Community Cancer Research United
- Enrollment36
- Start date2014-12-12
- ConditionsColorectal Adenocarcinoma · RAS Wild Type · Stage IV Colorectal Cancer AJCC v7 · Stage IVA Colorectal Cancer AJCC v7 · Stage IVB Colorectal Cancer AJCC v7
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.